http://xenical.forsecom.com
 RIDGEFIELD, Conn., Sept. 30 /PRNewswire/ -- With the announcement by Merck & Co. earlier today, recalling one of the most commonly prescribed arthritis medications, millions of arthritis patients worldwide will be working with their healthcare providers to re-evaluate their treatment. Boehringer Ingelheim Pharmaceuticals, Inc., makers of MOBIC(R) (meloxicam) tablets, expresse...
January 01 1970 01:00:00.
 The use of MOBIC for the treatment of the signs and symptoms of osteoarthritis was evaluated in the United Stats through a double-blind, controlled trial involving 464 patients treated with MOBIC for 12 weeks. MOBIC was shown to be effective in the treatment of osteoarthritis and demonstrated gastrointestinal tolerability similar to placebo. Outside the United States, the use...
October 13 2008 19:02:03.
 Mobic is a nonsteroidal anti-inflammatory drug (NSAID) in prescription form. It is used to relieve the pain and stiffness of osteoarthritis.Most important fact about this drugYou should have frequent checkups with your doctor if you take Mobic regularly. Like other nonsteroidal anti-inflammatory drugs, Mobic can cause ulcers or internal bleeding that occurs without warning....
August 05 2008 09:38:35.
 Serious problems from stomach ulcers such as bleeding are recognized complications in people treated with NSAIDs. Similar problems have occurred in people treated with Mobic. The likelihood of stomach problems increases the longer you take drugs like Mobic. However, even short-term treatment is not without risk. These problems can happen without any warning, but in some peopl...
August 05 2008 09:38:35.
 The cost rating is based on the average wholesale price for a drug. The average wholesale price is the suggested selling price for a drug, much like the sticker price on a car. Insurance companies often use this cost as the basis for drug reimbursement. This price does not reflect what you would pay for a drug if covered by your prescription benefit plan. For the ratings syst...
August 05 2008 09:38:35.
 NSAIDs cause an increased risk of serious gastrointestinal adverse events including bleeding, ulceration, and perforation of the stomach or intestines, which can be fatal. These events can occur at any time during use and without warning symptoms. Elderly patients are at greater risk for serious gastrointestinal events...Patients with a prior history of peptic ulcer disease a...
August 05 2008 09:38:35.
 Mobic is a nonsteroidal anti-inflammatory drug (NSAID). It may cause an increased risk of serious and sometimes fatal heart and blood vessel problems (eg, heart attack, stroke). The risk may be greater if you already have heart problems or if you take Mobic for a long time. Do not use Mobic right before or after bypass heart surgery.Serious stomach ulcers or bleeding can occu...
August 05 2008 09:38:35.
 RIDGEFIELD, CT (April 14, 2000) -- The U.S. Food and Drug Administration has approved MOBIC (meloxicam) tablets for marketing as a treatment for osteoarthritis. This decision gives patients in the United States an alternative that has been used in millions of patients worldwide for relieving the pain and stiffness associated with the disease. As the population ages, the need ...
August 05 2008 09:38:34.
| 
Info 